Citation Impact
Citing Papers
Interleukin-1 in the pathogenesis and treatment of inflammatory diseases
2011 Standout
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Immunomodulatory properties of mesenchymal stromal cells
2007 Standout
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
2011 Standout
Nonmyeloablative Allogeneic Hematopoietic Stem Cell Transplantation
2002
Guideline on the management of haemophilia in the fetus and neonate*
2011
Influence of the intensity of the conditioning regimen on the characteristics of acute and chronic graft‐versus‐host disease after allogeneic transplantation
2005
Ocular graft-versus-host disease
2012
Non‐genetic risk factors and the development of inhibitors in haemophilia: a comprehensive review and consensus report
2010
Guidelines for Preventing Infectious Complications among Hematopoietic Cell Transplantation Recipients: A Global Perspective
2009 Standout
Ocular Graft-versus-Host Disease: A Review
2013
Acute graft-vs-host disease
2001
TFOS DEWS II Diagnostic Methodology report
2017 Standout
Mesenchymal Stem Cell-Mediated Immunosuppression Occurs via Concerted Action of Chemokines and Nitric Oxide
2008 Standout
Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation
2000 Standout
Microbial translocation is a cause of systemic immune activation in chronic HIV infection
2006 Standout
Adoptive immunotherapy for cancer: building on success
2006
Pathology of graft-versus-host disease in the gastrointestinal tract
2009
Graft-versus-host disease and the Th1/Th2 paradigm
1996
TFOS DEWS II pathophysiology report
2017 Standout
Chimeric Antigen Receptor–Modified T Cells in Chronic Lymphoid Leukemia
2011 Standout
Tumor necrosis factor inhibitor ameliorates murine intestinal graft-versus-host disease
1999 StandoutNobel
Graft-versus-host disease
2009 Standout
The pathobiology of mucositis
2004 Standout
Effect of Solar Particle Event Radiation on Gastrointestinal Tract Bacterial Translocation and Immune Activation
2011 StandoutNobel
Reduced Mortality after Allogeneic Hematopoietic-Cell Transplantation
2010 Standout
CYTOKINE CASCADES IN ACUTE GRAFT-VERSUS-HOST DISEASE1
1997
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Tumor necrosis factor- alpha production to lipopolysaccharide stimulation by donor cells predicts the severity of experimental acute graft-versus-host disease.
1998
Hematopoietic Stem-Cell Transplantation
2006 Standout
The intestinal epithelial barrier: a therapeutic target?
2016 Standout
Earlier Low-Dose TBI or DST Overcomes CD8+ T-Cell-Mediated Alloresistance to Allogeneic Marrow in Recipients of Anti-CD40L
2003
T Cell Surveillance of Oncogene-Induced Prostate Cancer Is Impeded by T Cell-Derived TGF-β1 Cytokine
2011 StandoutNobel
Immunobiology of acute graft-versus-host disease
2003
Monoclonal antibodies for the prevention and treatment of graft-versus-host disease
2003
Bone marrow stromal cells attenuate sepsis via prostaglandin E2–dependent reprogramming of host macrophages to increase their interleukin-10 production
2008 Standout
Repertoire Enhancement with Adoptively Transferred Female Lymphocytes Controls the Growth of Pre-Implanted Murine Prostate Cancer
2012 StandoutNobel
Defining the Intensity of Conditioning Regimens: Working Definitions
2009 Standout
Cancer-related fatigue—mechanisms, risk factors, and treatments
2014 Standout
Mixed lymphohaemopoietic chimerism and graft-ver suslymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation
1999
Prognostic significance of increased IL-10 production in patients prior to allogeneic bone marrow transplantation
2000
Targeting Immunosupportive Cancer Therapies: Accentuate the Positive, Eliminate the Negative
2007 StandoutNobel
Immune modulation by mesenchymal stem cells
2006
Mucositis as a biological process: a new hypothesis for the development of chemotherapy-induced stomatotoxicity
1998
Gut Toxicity During Hemopoietic Stem Cell Transplantation May Predict Acute Graft-Versus-Host Disease Severity in Patients
2007
Impaired gut function as risk factor for invasive candidiasis in neutropenic patients
2002
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy
2004
Serum interleukin‐6 predicts the development of multiple symptoms at nadir of allogeneic hematopoietic stem cell transplantation
2008
Idiopathic pneumonia after bone marrow transplantation: Cytokine activation and lipopolysaccharide amplification in the bronchoalveolar compartment
1999
Total Body Irradiation and Acute Graft-Versus-Host Disease: The Role of Gastrointestinal Damage and Inflammatory Cytokines
1997
The role of endotoxin and the innate immune response in the pathophysiology of acute graft versus host disease
2002
Peripheral deletional tolerance of alloreactive CD8 but not CD4 T cells is dependent on the PD-1/PD-L1 pathway
2008 StandoutNobel
Modulation of acute graft-versus-host-disease after allogeneic bone marrow transplantation by tumor necrosis factor alpha (TNF alpha) release in the course of pretransplant conditioning: role of conditioning regimens and prophylactic application of a monoclonal antibody neutralizing human TNF alpha (MAK 195F)
1995
Human mesenchymal stem cells modulate allogeneic immune cell responses
2004 Standout
Change in plasma tumor necrosis factor receptor 1 levels in the first week after myeloablative allogeneic transplantation correlates with severity and incidence of GVHD and survival
2008
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation
2003
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Therapeutic Glucocorticoid-Induced TNF Receptor-Mediated Amplification of CD4+ T Cell Responses Enhances Antiparasitic Immunity
2010 StandoutNobel
Recipient Tumor Necrosis Factor- and Interleukin-10 Gene Polymorphisms Associate With Early Mortality and Acute Graft-Versus-Host Disease Severity in HLA-Matched Sibling Bone Marrow Transplants
1999
Interferon-gamma suppresses T-cell proliferation to mitogen via the nitric oxide pathway during experimental acute graft-versus-host disease
1996
CD8+tumor-infiltrating lymphocytes at primary sites as a possible prognostic factor of cutaneous angiosarcoma
2013 StandoutNobel
Interleukin-10 and the Interleukin-10 Receptor
2001 Standout
The primacy of the gastrointestinal tract as a target organ of acute graft-versus-host disease: rationale for the use of cytokine shields in allogeneic bone marrow transplantation
2000
Conversion of Alloantigen-Specific CD8+ T Cell Anergy to CD8+ T Cell Priming through In Vivo Ligation of Glucocorticoid-Induced TNF Receptor
2006 StandoutNobel
The Danger Model: A Renewed Sense of Self
2002 StandoutScience
Interleukin-1 blockade does not prevent acute graft-versus-host disease: results of a randomized, double-blind, placebo-controlled trial of interleukin-1 receptor antagonist in allogeneic bone marrow transplantation
2002
GITR Activation Induces an Opposite Effect on Alloreactive CD4+ and CD8+ T Cells in Graft-Versus-Host Disease
2004 StandoutNobel
The Role of Hyperuricemia in the Increased Cytokine Production After Lipopolysaccharide Challenge in Neutropenic Mice
1997
Novel therapeutics for the treatment of graft-versus-host disease
2002
Is There a Pathogenetic Role for Uric Acid in Hypertension and Cardiovascular and Renal Disease?
2003 Standout
Guidelines for the management of hemophilia
2012 Standout
Oral Sequelae of Head and Neck Radiotherapy
2003 Standout
The Balance Between Donor T Cell Anergy and Suppression Versus Lethal Graft-Versus-Host Disease Is Determined by Host Conditioning
2002
WFH Guidelines for the Management of Hemophilia, 3rd edition
2020 Standout
Preventing and Managing Toxicities of High-Dose Methotrexate
2016 Standout
Works of SA Brown being referenced
Early factor VIII exposure and subsequent inhibitor development in children with severe haemophilia A
2007
Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2- incompatible transplanted SCID mice
1994
Effect of total body irradiation, busulfan-cyclophosphamide, or cyclophosphamide conditioning on inflammatory cytokine release and development of acute and chronic graft-versus-host disease in H-2- incompatible transplanted SCID mice
1994